Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment
JENA, Germany, Feb. 9, 2022 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status
Stay updated with breaking news from Ulf Teichgr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JENA, Germany, Feb. 9, 2022 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status
SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly SIRONA Randomized Control Trial (RCT) which compares head-to-head, SIROlimus versus Paclitaxel Drug-Eluting Balloo N Angioplasty in femoropopliteal arterial diseases (SIRONA). SIRONA is the world's first RCT investigating the use of Sirolimus drug coated balloon (DCB) (MagicTouch PTA - Concept Medical) V/S Paclitaxel DCB for the treatment of femoropopliteal artery disease. SIRONA is an Investigator-Initiated and driven, prospective, multi-...